Application Nr Approved Date Route Status External Links
BLA125460 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Vimizim (Elosulfase Alfa) Is Indicated For Patients With Mucopolysaccharidosis Type Iva (Mps Iva; Morquio A Syndrome). Vimizim Is A Hydrolytic Lysosomal Glycosaminoglycan (Gag)-Specific Enzyme Indicated For Patients With Mucopolysaccharidosis Type Iva (Mps Iva; Morquio A Syndrome) ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Elosulfase Alfa

Comments